To assess the AD risk effect of ApoE genotypes ε3/ε4 and ε4/ε4 relative to the ε3/ε3 genotype, we restricted the sample set to those that were not ε2 allele carriers. The gene discussed is APOE; the disease is Alzheimer disease.